GW Pharmaceuticals Plc

Available to platforms

GW Pharmaceuticals Plc (Ticker: GWPH) was a biopharmaceutical company focused on developing cannabinoid-based medicines. Its flagship product, Epidiolex, became the first FDA-approved cannabidiol (CBD) treatment for epilepsy-related conditions, including Lennox-Gastaut syndrome and Dravet syndrome. In 2021, GW Pharmaceuticals was acquired by Jazz Pharmaceuticals, expanding its portfolio to include innovative treatments in neuroscience and oncology.

GW Pharmaceuticals Plc - GWPH stocks live chart

Analyze price movements of GW Pharmaceuticals Plc online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous GWPH quotes – including the latest bid at 218.8 USD and ask at 219.44 USD – and get all the necessary information for adding GW Pharmaceuticals Plc to your investment portfolio.

With R StocksTrader, you can invest in GW Pharmaceuticals Plc and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like GW Pharmaceuticals Plc, and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of GWPH does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for GW Pharmaceuticals Plc (GWPH).

You can trade GW Pharmaceuticals Plc (GWPH) on the R StocksTrader platform.

You can trade online GW Pharmaceuticals Plc (GWPH) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts